Vasamed, Inc.
VSMD · OTC
12/31/2005 | 12/31/2004 | 12/31/2003 | 12/31/2002 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | -0.01 | -0.96 | 0.08 |
| FCF Yield | -66.05% | -38.80% | -13.34% | -22.02% |
| EV / EBITDA | -1.63 | -1.71 | -5.95 | -6.18 |
| Quality | ||||
| ROIC | 742.82% | -166.94% | 211.46% | -638.30% |
| Gross Margin | -5.01% | -29.76% | 14.88% | 73.20% |
| Cash Conversion Ratio | 0.95 | 0.62 | 0.72 | 1.21 |
| Growth | ||||
| Revenue 3-Year CAGR | -13.26% | -12.11% | 45.64% | – |
| Free Cash Flow Growth | -21.52% | -131.43% | 27.80% | -99.19% |
| Safety | ||||
| Net Debt / EBITDA | -0.00 | 0.00 | 0.01 | 0.14 |
| Interest Coverage | 0.00 | 42.83 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 3.24 | 7.14 | 7.62 | 1.63 |
| Cash Conversion Cycle | 190.97 | 77.48 | 60.09 | 136.81 |